Comment by
tylerreddick on Oct 18, 2024 11:00pm
Well, either they are being honest and we will all be very happy in a few months, or they are lying through their teeth and we'll be pizzed. Welcome to the Vulture Exchange.
Comment by
MirrorWorldMan on Oct 22, 2024 11:00am
Investors don't believe these 'analysts' anymore, no revenue from previous compounds suggests no revenue from future compounds. Track record is dismal so what has changed? Bring in revenue from 1067 and the investors will folow.
Comment by
tylerreddick on Oct 22, 2024 11:25am
Well, Howie always made krappy deals with krappy companies to do his work for him. He finally realised that the only way to get product to market was to do it ourselves, like every other successful cosmetic company. So that has indeed changed. And like I said before, there is trillions of private equity money searching for a home. All we need is a miniscule amount of that money to look our way.
Comment by
forhandlaren on Oct 22, 2024 11:37am
The reference to Abbvie isn't the most clever idea I've come across.18 months ago - yes, 28 months after the deal - no. Starting to believe that Abbvie has shelved the compound so why not release a product by themseleves back to back on anti-aging?
Comment by
Turtle4 on Oct 22, 2024 11:44am
Remember the post deal news, where they said that allergan is already in an advanced state to commercialization?
Comment by
lscfa on Oct 22, 2024 3:10pm
Maybe SBM mgmt is planning on invoking the non-performance clause with Abbvie to raise some funds.
Comment by
MirrorWorldMan on Oct 23, 2024 11:47am
One thing is certain, extended silence on 1067 benefits nobody and brings to mind silence on Wannabang before they shelved our SGLT2, and all those other supposed partners in late stage talks foe whatever compound in whatever indication. Continued rhetoric with no revenue and extended dilutions can easily be seen as a scam. Shame on Howie and Hoppy.